BME
BlackRock Health Sciences Trust
43.30$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 151.2% | 556.5% | 141.1% | 18.1% | 153.4% | 16.5% | – | – | 8.9% | 69.8% | 12.6% | 8.9% | |
| 100.0% | -456.5% | 100.0% | 81.9% | 100.0% | 83.5% | 100.0% | – | 91.1% | 100.0% | 87.4% | 91.1% | |
| 79.7% | 293.6% | 72.4% | 13.8% | 78.9% | 35.9% | 78.8% | – | 152.3% | 75.5% | 11.2% | 9.2% | |
| 802.4% | 2,954.2% | 165.6% | 13.8% | 121.2% | 35.9% | 78.8% | – | 152.3% | 75.5% | -266.6% | 14.6% | |
| 20.3% | 6,646.1% | 27.6% | 68.1% | 21.1% | 47.6% | 21.2% | – | -61.2% | 24.5% | 354.0% | 76.4% | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | 0.0% | 0.1% | 0.1% | |
| 902.4% | 6,644.7% | 265.6% | 68.1% | 221.2% | 47.6% | 1,133.1% | – | -61.3% | -90.0% | 353.9% | 76.4% | |
| 882.1% | 0.0% | 238.1% | 0.0% | 200.1% | 0.0% | – | – | – | – | – | – | |
| 902.4% | 6,644.7% | 265.6% | 68.1% | 221.2% | 47.6% | 1,133.1% | – | -61.3% | -90.0% | 353.9% | 76.4% | |
| 882.1% | 6,646.1% | 238.1% | 68.1% | 200.1% | 47.6% | – | – | -61.2% | 24.5% | 354.0% | 76.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.